Actively Recruiting

Age: 18Years - 75Years
All Genders
Healthy Volunteers
NCT07514897

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2026-04-07

250

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will, for the first time, establish a non-invasive diagnostic model for bladder cancer based on CREPT expression levels in exfoliated urothelial cells using a multicenter cohort, and validate its value in the non-invasive diagnosis and recurrence monitoring of bladder cancer. Its high sensitivity is expected to overcome the technical limitations of existing biomarkers and provide an innovative solution for establishing an integrated precision diagnosis and treatment system encompassing "screening, diagnosis, and monitoring."

CONDITIONS

Official Title

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

Who Can Participate

Age: 18Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with or suspected of having bladder cancer
  • Patients with benign urological diseases such as ureteral calculi, bladder calculi, cystitis, or ureteral stricture
  • Consent to use of experimental urine and tissue specimens
  • Aged 18 to 75 years
  • Willing to sign informed consent, follow the study plan, and attend follow-up visits
Not Eligible

You will not qualify if you...

  • History of other malignant tumors within the past 5 years or prior anti-cancer treatment
  • Urothelial carcinoma with other genitourinary tumors like kidney or prostate cancer
  • Non-standard sample collection or storage procedures
  • Incomplete relevant participant information
  • Inability to communicate, understand, or cooperate, leading to poor compliance
  • Investigator judgment deeming participant unsuitable for the trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences

Beijing, Chaoyang District, China, 100021

Actively Recruiting

Loading map...

Research Team

X

Xiongjun Ye

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring | DecenTrialz